Leukemia inhibitory factor production by rat mast cells

J S Marshall1, J Gauldie, L Nielsen

  • 1Molecular Virology and Immunology Programme, McMaster University, Hamilton, Ontario, Canada.

Insights

Mast cells produce Leukemia inhibitory factor (LIF), a cytokine crucial for immune responses, neuronal development, and bone metabolism. This production can be enhanced, suggesting a significant role for mast cells in various physiological processes.

Area of Science:

  • Immunology
  • Cell Biology
  • Cytokine Signaling

Background:

  • Leukemia inhibitory factor (LIF) is a cytokine involved in immune regulation, inflammation, neuronal development, and bone metabolism.
  • Mast cells are immune cells known for their role in allergic reactions and inflammation.

Purpose of the Study:

  • To investigate the production of LIF at both mRNA and bioactivity levels in rat mast cells and mast cell lines.
  • To determine if mast cell activation influences LIF production.

Main Methods:

  • Utilized hepatocyte-stimulating factor activity assay to measure LIF bioactivity.
  • Employed neutralizing antibodies specific for LIF to confirm its presence.
  • Analyzed mRNA expression of LIF in mast cells.
  • Treated mast cells with calcium ionophore A23187 to assess activation effects.

Main Results:

  • Two rat mast cell lines (RBL.2H3 and RCMC9) demonstrated endogenous production of LIF bioactivity.
  • LIF production by mast cell lines was enhanced upon treatment with calcium ionophore A23187.
  • Freshly isolated rat peritoneal mast cells expressed LIF mRNA.
  • No interleukin-6 production was detected in mast cells under the tested conditions.

Conclusions:

  • Rat mast cells, including primary cells and cell lines, produce Leukemia inhibitory factor (LIF).
  • LIF production by mast cells can be modulated by activation stimuli.
  • These findings highlight a potential role for mast cells in processes regulated by LIF, such as neuronal development, hematopoiesis, bone metabolism, and acute-phase responses.